Policies

PharmaZen is dedicated to cultivating our Environmental, Social, and Governance (ESG) framework, aspiring to achieve the utmost standards through unwavering accountability, transparent practices and a commitment to continual enhancement.

Business Principles

Our organizational ethos is anchored in delivering value to our stakeholders, embracing principles that prioritize people and the planet.

Innovation

We foster a culture of innovation that permeates every facet and echelon of our operations.

Diversity and Inclusion

We prioritize inclusivity, recognizing the inherent value in accessing a broad spectrum of skills, experiences and perspectives.

Safety

Our paramount concern extends to the safety of both individuals and products alike.

Functionality

We uphold functional excellence in all operational aspects, ensuring efficacy and reliability.

Sustainability

We are steadfast in our dedication to sustainable practices that harmonize with environmental and societal needs, both present and future.

Sustainability Initatives

Sustainability stands as the bedrock of our investments, ensuring the wellbeing of both people and the planet, while upholding the highest standards of ethical conduct and social responsibility. Our commitment is evident in a range of initiatives which exemplify our enduring dedication to sustainability and responsible business practices, driving positive impact within our communities and beyond.

Pioneering Technology Adoption

Embracing cutting-edge technologies such as High-Pressure Processing (HPP) to drive innovation and efficiency.

Greenhouse Gas (GHG) Reduction

Proactively transitioning away from GHG-causing refrigerants, optimizing efficiency while minimizing environmental impact.

Waste Management

Implementing robust waste reduction strategies, including upgrading waste streams to meet edible/feed grade standards.

Living Wage Guarantee

Ensuring all employees receive a minimum living wage, fostering economic security and dignity.

Comprehensive Benefits

Providing comprehensive medical insurance coverage, prioritizing the health and well-being of our workforce.

Child Welfare Advocacy

Extending our commitment to child welfare policies to cover our suppliers, fostering a culture of care and responsibility.

Diversity and Inclusion

Upholding a steadfast commitment to diversity and inclusion, valuing and leveraging the diverse perspectives and talents within our organization.

Directors

Ken Fergus
Ken Fergus
Appointed Chairman, May 2019

Ken joined the board of PharmaZen in August 2006 and became chair in 2019. Ken holds a Bachelor of Commerce (Accounting and Marketing) from the University of Otago and earned his CA designation in 1973. His extensive career includes a partnership at Ernst & Young from 1978 to 2006, where he was the Managing Director in both Dunedin and Christchurch offices and served on the national board of management. Transitioning to governance roles, Ken had director roles in substantial private companies across manufacturing, property, and service sectors. Notably, he has chaired PharmaZen since 2018 and founded Dalmore Consulting, specialising in financial advisory services. Ken's directorships extend to McCrae Management Group, David Lyall Holdings, and McNulty’s Investments, among others. Within the community, Ken has chaired the Christchurch Golf Club and held board positions at St Hilda’s Collegiate School, Rangi Ruru Girls’ School, and the Otago Artificial Surface Trust. He was also engaged in Rotary International. Ken's governance expertise lies in establishing robust structures and managing risks, policies, and financial performance, enhancing the effectiveness of the organisations he serves.

Craig McIntosh
Craig McIntosh
Appointed Managing Director March 2019

Craig holds a Bachelor of Commerce and brings 19 years of experience as Managing Director. Before joining PharmaZen in 2005, Craig held senior management positions in primary produce, technology, and branded product companies with a strong international focus. Craig’s background includes notable roles at Canterbury of New Zealand Limited, Alliance Textiles Limited (including Swanndri), and Whisper Tech Limited, among others. Since joining PharmaZen, Craig has steered the company through various challenges, including earthquakes, pandemics, and the global financial crisis. Under his leadership, PharmaZen has transformed from a company experiencing operating losses to one boasting a turnover of $29 million, underlying EBITDA of $4.2 million, and a robust plant and equipment asset base of $55 million. Craig's strategic vision and focus on building world-class extraction and freeze-drying facilities have been instrumental in PharmaZen's success.

Dr Wayne Burt
Dr Wayne Burt
Appointed November 2009

Wayne is a successful New Zealand expatriate investor based in Europe. He holds a BA (Hons) and PhD in Economics from the University of Otago (1984), a PGD in Applied Finance from the Securities Institute Australia (1986), and a PMD from Harvard Business School (1992). He has been the principal of Lotus Capital Partners Limited since its establishment in 1995. With a diverse career spanning various industries, Wayne has been a Director at PharmaZen since 2009, contributing significantly to its growth and success. His earlier roles included directorships at Deutsche Bank Australia Limited and Macquarie Bank Australia Limited, where he spearheaded equity capital markets divisions. Wayne has founded and/or led the venture funding for many highly successful companies in several different countries. Of particular relevance to NZ and Australia is his founding of two ‘Unicorn” companies. He Co-founded A2 Milk Company Limited with Howard Paterson and Dr Corrie McLachlan in 2000; with his company providing all initial venture capital; he remained a Director for the first ten years; A2 reached peak market capitalisation of circa NZ$14bill – then NZ’s second largest company. In Australia he founded the Northern and Southern Television companies, which later merged with Liberty Global to form Austar United Communications and become a major player in Australia's pay-TV sector; and ultimately sold to Foxtel in a multi-billion dollar transaction. Wayne remains an active investor, especially in health and wellness, cutting-edge technologies, and sustainable ventures. He brings to PharmaZen a track record of success across diverse sectors, embodying a blend of academic excellence, strategic vision, and entrepreneurial drive.

Vincent Pooch
Vincent Pooch
Appointed September 2023

Vincent is based in Christchurch. Qualified as a Mechanical Engineer and Chartered Accountant, he founded a consulting practice in 1992 after working in finance. In the decades since then, he has guided a diverse customer base spanning primary industries such as cement manufacturing, quarrying and logistics, in NZ and internationally. Today Vincent’s focus is governance. He is a Chartered Fellow of the Institute of Directors in New Zealand and served on their National Council. Past and present Board roles include Port Otago, Dynes Transport, Smith Cranes and manufacturer Patchell Industries. Vincent’s directorship brings a strong financial focus, with a particular interest in risk management, strategy and leadership development in businesses that add value to New Zealand resources.

Jessie Chan MNZM
Jessie Chan MNZM
Appointed February 2024

Jessie is based in Rakaia (Canterbury). Qualified with an Honours Degree in Animal Science, she has worked in a range of primary sector management positions over twenty years including Central Government, Local Government, non-profit and commercial organisations. Jessie has also owned and co-managed a farming business in Dorie, milking 900 cows on 420 ha and is an equity partner in a farm at Springston. She is currently a director of AgResearch, NZ Pork and AgriZero. Jessie has previously served on the Board of RuralCo, Ngai Tahu Farming Ltd, Alpine Energy Ltd, Meat the Need and Bioprotection Aotearoa. Jessie was awarded a Member of the NZ Order of Merit in 2022 for services to dairy and agriculture. She also received the Women in Governance Award for Inspiring Governance Leader in 2021, and Dairy Woman of the Year in 2017.

Ken Fergus
Ken Fergus
Appointed Chairman, May 2019

Ken joined the board of PharmaZen in August 2006 and became chair in 2019. Ken holds a Bachelor of Commerce (Accounting and Marketing) from the University of Otago and earned his CA designation in 1973. His extensive career includes a partnership at Ernst & Young from 1978 to 2006, where he was the Managing Director in both Dunedin and Christchurch offices and served on the national board of management. Transitioning to governance roles, Ken had director roles in substantial private companies across manufacturing, property, and service sectors. Notably, he has chaired PharmaZen since 2018 and founded Dalmore Consulting, specialising in financial advisory services. Ken's directorships extend to McCrae Management Group, David Lyall Holdings, and McNulty’s Investments, among others. Within the community, Ken has chaired the Christchurch Golf Club and held board positions at St Hilda’s Collegiate School, Rangi Ruru Girls’ School, and the Otago Artificial Surface Trust. He was also engaged in Rotary International. Ken's governance expertise lies in establishing robust structures and managing risks, policies, and financial performance, enhancing the effectiveness of the organisations he serves.

Craig McIntosh
Craig McIntosh
Appointed Managing Director March 2019

Craig holds a Bachelor of Commerce and brings 19 years of experience as Managing Director. Before joining PharmaZen in 2005, Craig held senior management positions in primary produce, technology, and branded product companies with a strong international focus. Craig’s background includes notable roles at Canterbury of New Zealand Limited, Alliance Textiles Limited (including Swanndri), and Whisper Tech Limited, among others. Since joining PharmaZen, Craig has steered the company through various challenges, including earthquakes, pandemics, and the global financial crisis. Under his leadership, PharmaZen has transformed from a company experiencing operating losses to one boasting a turnover of $29 million, underlying EBITDA of $4.2 million, and a robust plant and equipment asset base of $55 million. Craig's strategic vision and focus on building world-class extraction and freeze-drying facilities have been instrumental in PharmaZen's success.

Dr Wayne Burt
Dr Wayne Burt
Appointed November 2009

Wayne is a successful New Zealand expatriate investor based in Europe. He holds a BA (Hons) and PhD in Economics from the University of Otago (1984), a PGD in Applied Finance from the Securities Institute Australia (1986), and a PMD from Harvard Business School (1992). He has been the principal of Lotus Capital Partners Limited since its establishment in 1995. With a diverse career spanning various industries, Wayne has been a Director at PharmaZen since 2009, contributing significantly to its growth and success. His earlier roles included directorships at Deutsche Bank Australia Limited and Macquarie Bank Australia Limited, where he spearheaded equity capital markets divisions. Wayne has founded and/or led the venture funding for many highly successful companies in several different countries. Of particular relevance to NZ and Australia is his founding of two ‘Unicorn” companies. He Co-founded A2 Milk Company Limited with Howard Paterson and Dr Corrie McLachlan in 2000; with his company providing all initial venture capital; he remained a Director for the first ten years; A2 reached peak market capitalisation of circa NZ$14bill – then NZ’s second largest company. In Australia he founded the Northern and Southern Television companies, which later merged with Liberty Global to form Austar United Communications and become a major player in Australia's pay-TV sector; and ultimately sold to Foxtel in a multi-billion dollar transaction. Wayne remains an active investor, especially in health and wellness, cutting-edge technologies, and sustainable ventures. He brings to PharmaZen a track record of success across diverse sectors, embodying a blend of academic excellence, strategic vision, and entrepreneurial drive.

Vincent Pooch
Vincent Pooch
Appointed September 2023

Vincent is based in Christchurch. Qualified as a Mechanical Engineer and Chartered Accountant, he founded a consulting practice in 1992 after working in finance. In the decades since then, he has guided a diverse customer base spanning primary industries such as cement manufacturing, quarrying and logistics, in NZ and internationally. Today Vincent’s focus is governance. He is a Chartered Fellow of the Institute of Directors in New Zealand and served on their National Council. Past and present Board roles include Port Otago, Dynes Transport, Smith Cranes and manufacturer Patchell Industries. Vincent’s directorship brings a strong financial focus, with a particular interest in risk management, strategy and leadership development in businesses that add value to New Zealand resources.

Jessie Chan MNZM
Jessie Chan MNZM
Appointed February 2024

Jessie is based in Rakaia (Canterbury). Qualified with an Honours Degree in Animal Science, she has worked in a range of primary sector management positions over twenty years including Central Government, Local Government, non-profit and commercial organisations. Jessie has also owned and co-managed a farming business in Dorie, milking 900 cows on 420 ha and is an equity partner in a farm at Springston. She is currently a director of AgResearch, NZ Pork and AgriZero. Jessie has previously served on the Board of RuralCo, Ngai Tahu Farming Ltd, Alpine Energy Ltd, Meat the Need and Bioprotection Aotearoa. Jessie was awarded a Member of the NZ Order of Merit in 2022 for services to dairy and agriculture. She also received the Women in Governance Award for Inspiring Governance Leader in 2021, and Dairy Woman of the Year in 2017.

Governance Structure

Board of Directors

Minimum of three Directors and maximum of seven directors. At least two Directors must be ordinarily resident in New Zealand. Each year one third of the Directors shall retire from office, but shall be eligible for re-election at that meeting. The board is responsible for managing, directing and supervising the management of the business and affairs of the company.

Managing Director

Implement the company's long term strategic goals and objectives to drive growth and profitability. Oversee day to day operations, ensuring that business processes are efficient, effective and aligned with the company's strategic objectives. Lead, mentor and develop the executive team and senior management, fostering a positive organizational culture and high levels of employee engagement. Build and maintain relationships with key stakeholders, including investors, customers, partners and regulators, to support the company's interests and enhance its reputation.

Chief Financial Officer

Manage the company's financial affairs, including budgeting, forecasting and financial reporting, to ensure fiscal health and accountability. Ensure that the company complies with all legal and regulatory requirements and develop risk management strategies to protect the company's assets and interests.

Factory